Effects of p53 mutation on tumor progression: recent insights from mouse tumor models.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1996-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0304-419X(95)00013-6PMID 8603069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.

  1995cited by this paper
• A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient mice

  1995cited by this paper
• Induction of apoptosis by tumor suppressor genes and oncogenes.

  1995cited by this paper
• Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

  1995cited by this paper
• Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.

  1995cited by this paper
• p53 abnormalities and genomic instability in primary human breast carcinomas.

  1995cited by this paper
• Growth factor modulation of p53-mediated growth arrest versus apoptosis.

  1995cited by this paper
• Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

  1995cited by this paper
• A p53-dependent mouse spindle checkpoint

  1995cited by this paper
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens

  1994cited by this paper
• Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.

  1994cited by this paper
• Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

  1994cited by this paper
• Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

  1994cited by this paper
• Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.

  1994cited by this paper
• Transcriptional activation by p53 correlates with suppression of growth but not transformation.

  1994cited by this paper
• Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.

  1994cited by this paper
• 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.

  1994cited by this paper
• Testing the Role of p53 in the Expression of Genetic Instability and Apoptosis in Ataxia-telangiectasia.

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• Relationship of p53 to the control of apoptotic cell death.

  1994cited by this paper
• Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

  1994cited by this paper
• The role of p53 in tumor progression.

  1994cited by this paper
• Sequence-specific transcriptional activation is essential for growth suppression by p53.

  1994cited by this paper
• Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

  1994cited by this paper
• p53-dependent apoptosis suppresses tumor growth and progression in vivo.

  1994cited by this paper
• Germline p53 mutations and heritable cancer.

  1994cited by this paper
• Molecular dissection of multi-stage tumorigenesis in transgenic mice.

  1994cited by this paper
• Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

  1993cited by this paper
• Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

  1993cited by this paper
• Thymocyte apoptosis induced by p53-dependent and independent pathways

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.

  1993cited by this paper
• Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• Gain of function mutations in p53

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

  1993cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression.

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• Wild-type p53 activates transcription in vitro

  1992cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression

  1992cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

  1992cited by this paper
• A transcriptionally active DNA-binding site for human p53 protein complexes

  1992cited by this paper
• Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

  1992cited by this paper
• Definition of a consensus binding site for p53

  1992cited by this paper
• Wild-type p53 binds to the TATA-binding protein and represses transcription.

  1992cited by this paper
• High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA Aneuploidy

  1992cited by this paper
• Increased p53 protein content of colorectal tumours correlates with poor survival.

  1992cited by this paper
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

  1992cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

  1991cited by this paper
• Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.

  1991cited by this paper
• Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.

  1991cited by this paper
• Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

  1990cited by this paper
• Fibroblast growth factor. Chemical structure and biologic function.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

  1989cited by this paper
• The clonal nature of neoplasia.

  1989cited by this paper
• The clonal nature of neoplasia.

  1989cited by this paper
• Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.

  1988cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper

• Hepatocyte apoptotic index and p53 expression in obstructive jaundice rats.

  2014cites this paper
• Studying p53-dependent cell death in vitro and in vivo.

  2008cites this paper
• Regulation of endoplasmic reticulum stress induced apoptosis in human melanoma.

  2008cites this paper
• THE FUNCTIONAL SIGNIFICANCE OF AN ALTERNATELY SPLICED PRODUCT OF THE HDM2 GENE

  2007cites this paper
• Genetic mapping of a putative tumor suppressor locus that influences tumorigenesis and metastasis in mice

  2006cites this paper
• Novel P53 mutations detected by FAMA in colorectal cancers.

  2006cites this paper
• Nuclear Accumulations of p53 and Mdm2 are Accompanied by Reductions in c-Abl and p300 in Zinc-Depleted Human Hepatoblastoma Cells

  2006cites this paper
• IDENTIFICATION OF GENES THAT COOPERATE WITH P53 IN TUMORIGENESIS

  2006cites this paper
• Genomic Basis of Breast Cancer

  2004cites this paper
• Absence of p21Waf1/Cip1/Sdi1 Modulates Macrophage Differentiation and Inflammatory Response and Protects Against Atherosclerosis

  2004cites this paper
• Absence of p21 Modulates Macrophage Differentiation and Inflammatory Response and Protects Against Atherosclerosis

  2004cites this paper
• Macrophage-Specific p53 Expression Plays a Crucial Role in Atherosclerosis Development and Plaque Remodeling

  2003cites this paper
• The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells.

  2003cites this paper
• Regulatory mechanisms in the stabilization of p53 tumor suppressor gene in zinc depleted hepatoblastoma cells

  2003cites this paper
• Molecular Evolutionary Patterns in Breast Cancer

  2003cites this paper
• Analysis of mutational spectra: locating hotspots and clusters of mutations using recursive segmentation

  2002cites this paper
• The p53-Deficient Mouse as a Cancer Model

  2002cites this paper
• Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and Bax expression in endothelial cells.

  2002cites this paper
• Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c‐myc in the liver

  2001cites this paper
• Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53

  2000cites this paper
• Mutant p53 and genomic instability in a transgenic mouse model of breast cancer

  2000cites this paper
• p53 and cell-cycle control: a finger in every pie.

  2000cites this paper
• Hereditary breast cancer: a review.

  2000cites this paper
• Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.

  2000cites this paper
• P53 null mice: damaging the hypothesis?

  2000cites this paper
• p53 and human cancer: the first ten thousand mutations.

  2000cites this paper
• Nitric Oxide and Cancer

  2000cites this paper
• Antitumor effect of vaccinia virus in glioma model.

  1999cites this paper
• Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin.

  1999cites this paper
• Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.

  1999cites this paper
• The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo

  1999cites this paper
• Microsatellite instability during the immortalization and transformation of human breast epithelial cells in vitro

  1999cites this paper
• Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein

  1999cites this paper
• Microbial induction of programmed cell death in the gastrointestinal tract

  1999cites this paper
• Mechanismen der Entstehung genetisch bedingter Krebsformen

  1998cites this paper
• Murine tumor suppressor models.

  1998cites this paper
• A transgenic mouse model for mammary carcinogenesis

  1998cites this paper
• Measurement of micronucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene

  1998cites this paper
• Biological and molecular basis of human breast cancer.

  1998cites this paper
• Comparative anticancer effects of vaccination and dietary factors on experimentally-induced cancers.

  1998cites this paper
• p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis

  1997cites this paper
• The role of p53 tumor-associated protein in colon cancer detection and prevention (Review).

  1997cites this paper
• Mechanism of p53 degradation.

  1997cites this paper
• PhenytoinおよびNifedipineにより誘発された歯肉増殖症についての免疫組織化学的研究 : p53タンパク質およびKi-67抗原の発現について

  1997cites this paper
• Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection.

  1997cites this paper
• Characterisation of the Myc negative autoregulation mechanism

  1997cites this paper